insights_auto
Why is BVNRY up 3.30%?
Dive Deeperchevron_right
BVNRY:OTCMKTS
Bavarian Nordic A/S - ADR
$11.46
arrow_upward
+3.30%(+0.37) 1D
Oct 8, 1:27:20 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BVNRY...
Open
$11.54
High
$11.54
Low
$11.45
Mkt. cap
2.72B
Avg. vol.
2.52K
Volume
7.47K
P/E ratio
12.24
52-wk high
$13.00
52-wk low
$8.67
EPS
$0.94
Beta
1.45
Shares outstanding
237.82M
No. of employees
2K
Open
$11.54
High
$11.54
Low
$11.45
Mkt. cap
2.72B
Avg. vol.
2.52K
Volume
7.47K
P/E ratio
12.24
52-wk high
$13.00
52-wk low
$8.67
EPS
$0.94
Beta
1.45
Shares outstanding
237.82M
No. of employees
2K
News stories
From web sources and news partners
The Copenhagen Post
·
5 hours ago
Bavarian Nordic raises 2026 revenue forecast on stronger travel vaccine sales
MedWatch
·
10 hours ago
Bavarian Nordic's guidance raise bigger than expected, analyst says
Investing.com
·
10 hours ago
Why is Bavarian Nordic stock surging today?
Yahoo Finance
·
11 hours ago
Bavarian Nordic lifts revenue, margin outlook on U.S. rabies vaccine demand
Profile
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
About Bavarian Nordic A/S - ADR
CEOPaul Chaplin
Employees1.91K
FoundedJul 1, 1992
Headquarters-
SectorBiotechnology
Websitebavarian-nordic.com